On July 3, 2023, Fukuda Denshi Co., Ltd., announced that it held its 76th Extraordinary General Meeting of Shareholders on June 29, 2023 and according to the voting results, the shareholder proposals by Japan Absolute Value Fund L.P., on (i) Abolition of ?Basic Policy on Countermeasures against Large-scale Purchase of Company Shares?, (ii) Amendment to Articles of Incorporation (Establishment of new provisions regarding countermeasures against large-scale purchase), (iii) Method of determining the amount of remuneration for each individual director, and (iv) Amendment to Articles of Incorporation (Establishment of new provision regarding method of determining the amount of remuneration for directors) were all rejected.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.